Data / Form D filings / Dual Therapeutics, LLC
Dual Therapeutics, LLC: Form D filings
Dual Therapeutics, LLC, a pharmaceuticals company in New York, NY, filed 3 Form D notices with the SEC between 2013 and 2014. The latest, on October 21, 2014, reports $6.4 million sold of a $15.3 million offering to 11 investors.
Find out what Dual Therapeutics, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 423 W. 127TH STREET, New York, NY, 10027
- Phone
- (216) 455-3216
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2013
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1575797
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 21, 2014 | Amendment | $15,309,611 | $6,377,000 | $8,932,611 | 11 | Jul 11, 2013 | sec.gov |
| Jun 17, 2014 | Amendment | $7,500,000 | $3,689,611 | $3,810,389 | 9 | Jul 11, 2013 | sec.gov |
| Jul 17, 2013 | New notice | $2,500,000 | $893,372 | $1,606,628 | 8 | Jul 11, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David U'Prichard | Director | |
| Michael Ohlmeyer | Director | |
| Al Hawkins | Promoter | |
| Baiju Shah | Director, Promoter |
Other pharmaceuticals companies in New York that filed recently
- NBO Pharma Inc. $238,000 · Nov 9, 2026
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Oct 20, 2014 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Dual Therapeutics, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.